Search
Research
The Youth Safe Haven Café ProjectThe Youth Safe Haven Project will co-design a youth-specific Safe Haven Café within the Peel Health Hub to serve as an alternative to the emergency department for young people at risk of suicide.
Research
WA Aboriginal Child Health Survey (WAACHS) Linked Data StudyThis study is a partnership between researchers, the Aboriginal community and government to provide evidence for policy and practice addressing high priority health and wellbeing issues for Aboriginal children and families.
Research
WA Epithelial Research Program for Childhood Respiratory DiseasesOnce thought to be a simple barrier to the external environment, epithelial cells are involved in many repair and inflammatory processes that occur in childhood airway diseases.
Research
Wellbeing studyBurns are a common cause of emergency presentations, and most burn injuries happen to children and adolescents.
The Institute is committed to mitigating its exposure to modern slavery risk in our operations and impact.
Protecting your privacy is important to us. This policy explains how The Kids Research Institute Australia collects, uses, and safeguards your personal information.
Our vision for reconciliation is a future where Aboriginal and Torres Strait Islander children and families experience equity in health, wellbeing and opportunity – empowered by partnerships grounded in respect, collaboration, and benefit.
Research
The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathyThe clinical understanding of the CDKL5 disorder remains limited, with most information being derived from small patient groups seen at individual centres.
Research
Breastfeeding in the first hour of life protects against neonatal mortalityBreastfeeding within the first hour of life has been shown to reduce high neonatal mortality by 22%.
Research
Efficacy of acute myeloid leukemia therapy without stem-cell transplantation in a child with blastic plasmacytoid dendritic cell neoplasmOur case demonstrates that AML therapy, without HSCT, can be sufficient to treat this rare disease in children.